BRCA1/2 Mutation Carriers and Risk Reduction Strategies Quiz
17 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following genes is associated with the highest lifetime risk of ovarian cancer among the moderate penetrance genes mentioned?

  • RAD51C
  • ATM
  • RAD51D (correct)
  • BRIP1
  • At what approximate age range is the risk of ovarian cancer highest for individuals with mutations in the BRIP1 and RAD51D genes?

  • 45-59 years (correct)
  • 70-79 years
  • 60-69 years
  • 35-39 years
  • Based on the information provided, which of the following statements is true regarding the management of ovarian cancer risk for women with moderate penetrance gene mutations?

  • Both b and c (correct)
  • Recommendations should be tailored based on family history and other risk factors.
  • RRSO is not indicated for women with an average risk of ovarian cancer.
  • Risk-reducing salpingo-oophorectomy (RRSO) is routinely recommended for all women with moderate penetrance gene mutations.
  • According to the information provided, what is the approximate lifetime risk of ovarian cancer for individuals with a mutation in the ATM gene?

    <p>3%</p> Signup and view all the answers

    Which of the following risk thresholds is generally used in the UK for considering risk-reducing surgery (RRSO) for ovarian cancer?

    <p>5%</p> Signup and view all the answers

    Based on the information provided, which of the following statements is true regarding the risk of ovarian cancer for women with one affected first-degree relative?

    <p>The risk is approximately 3%.</p> Signup and view all the answers

    Which of the following statements about BRCA1/2 mutation carriers is correct based on the provided information?

    <p>Prophylactic mastectomy at age 25 and prophylactic oophorectomy at age 40 maximize survival probability.</p> Signup and view all the answers

    According to the information provided, what is the estimated risk of male breast cancer for BRCA1 mutation carriers by age 70?

    <p>~7%</p> Signup and view all the answers

    Which of the following statements about the management of pancreatic cancer risk in BRCA1/2 mutation carriers is correct?

    <p>There is no proven screening approach for pancreatic cancer in BRCA1/2 mutation carriers.</p> Signup and view all the answers

    Which of the following genes, in addition to BRCA1/2, should be considered when evaluating inherited risk of breast and ovarian cancer?

    <p>PALB2 and ATM</p> Signup and view all the answers

    Based on the provided information, which of the following statements about prostate cancer screening for BRCA2 mutation carriers is correct?

    <p>Prostate cancer screening with PSA and DRE is recommended starting at age 40-45.</p> Signup and view all the answers

    According to the information provided, which of the following statements about the management of melanoma risk in BRCA1/2 mutation carriers is correct?

    <p>Dermatology skin screening and exposure reduction are recommended.</p> Signup and view all the answers

    What is the estimated lifetime risk of breast cancer for individuals with a pathogenic variant in the BARD1 gene?

    <p>Approximately 30%</p> Signup and view all the answers

    Which of the following genes is associated with the highest lifetime risk of ovarian cancer among the moderate-penetrance genes mentioned in the text?

    <p>BRIP1</p> Signup and view all the answers

    According to the UK consensus guidelines, what is the recommended screening strategy for women with a pathogenic variant in a moderate-penetrance breast cancer gene?

    <p>Annual mammography and MRI screening from age 30</p> Signup and view all the answers

    According to the information provided, what is the approximate percentage of ovarian cancer patients who have a germline mutation?

    <p>15-20%</p> Signup and view all the answers

    According to the UK consensus recommendations, which of the following genes should be considered when evaluating inherited risk of breast and ovarian cancer, in addition to BRCA1/2?

    <p>All of the above</p> Signup and view all the answers

    More Like This

    BRCA Gene Testing Quiz
    5 questions

    BRCA Gene Testing Quiz

    MesmerizingJustice avatar
    MesmerizingJustice
    BRCA1 and BRCA2 Mutations Quiz
    20 questions

    BRCA1 and BRCA2 Mutations Quiz

    MiraculousBildungsroman4805 avatar
    MiraculousBildungsroman4805
    Cell Division and Tumor Suppressor Genes
    37 questions
    Use Quizgecko on...
    Browser
    Browser